361 related articles for article (PubMed ID: 22743618)
1. N-Benzoyl-12-nitrodehydroabietylamine-7-one, a novel dehydroabietylamine derivative, induces apoptosis and inhibits proliferation in HepG2 cells.
Lin LY; Bao YL; Chen Y; Sun LG; Yang XG; Liu B; Lin ZX; Zhang YW; Yu CL; Wu Y; Li YX
Chem Biol Interact; 2012 Aug; 199(2):63-73. PubMed ID: 22743618
[TBL] [Abstract][Full Text] [Related]
2. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects and pro-apoptotic mechanism of TBIDOM, a novel dehydroabietylamine derivative, on human hepatocellular carcinoma SMMC-7721 cells.
Li F; He L; Song ZQ; Yao JC; Rao XP; Li HT
J Pharm Pharmacol; 2008 Feb; 60(2):205-11. PubMed ID: 18237468
[TBL] [Abstract][Full Text] [Related]
4. Juglanthraquinone C, a novel natural compound derived from Juglans mandshurica Maxim, induces S phase arrest and apoptosis in HepG2 cells.
Yao Y; Zhang YW; Sun LG; Liu B; Bao YL; Lin H; Zhang Y; Zheng LH; Sun Y; Yu CL; Wu Y; Wang GN; Li YX
Apoptosis; 2012 Aug; 17(8):832-41. PubMed ID: 22484481
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative effects of cucurmosin on human hepatoma HepG2 cells.
Xie J; Que W; Liu H; Liu M; Yang A; Chen M
Mol Med Rep; 2012 Jan; 5(1):196-201. PubMed ID: 21964700
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
Qin Y; Pan X; Tang TT; Zhou L; Gong XG
Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
[TBL] [Abstract][Full Text] [Related]
8. [Cinnamaldehyde ofloxacin-3-ylhydrazone induces apoptosis of human hepatocarcinoma SMMC-7721 cells].
Ren Z; Kang YH; Shi ZY; Huang-Fu CS; Hu GQ; Liu B
Yao Xue Xue Bao; 2010 Sep; 45(9):1109-15. PubMed ID: 21351566
[TBL] [Abstract][Full Text] [Related]
9. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
10. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells.
Handayani T; Sakinah S; Nallappan M; Pihie AH
Anticancer Res; 2007; 27(2):965-71. PubMed ID: 17465228
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
[TBL] [Abstract][Full Text] [Related]
13. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
Yingkun N; Lvsong Z; Huimin Y
Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
[TBL] [Abstract][Full Text] [Related]
14. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells.
Choi MJ; Jung KH; Kim D; Lee H; Zheng HM; Park BH; Hong SW; Kim MH; Hong S; Hong SS
Cancer Lett; 2011 Jul; 306(2):190-6. PubMed ID: 21463918
[TBL] [Abstract][Full Text] [Related]
16. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
[TBL] [Abstract][Full Text] [Related]
17. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
[TBL] [Abstract][Full Text] [Related]
18. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
19. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
20. VI-16, a newly synthesized flavonoid, induces apoptosis through the mitochondrial pathway in human hepatoma cells.
Lu N; Wei L; Gong D; Gao Y; Dai Q; Li Z; Guo Q
Oncol Rep; 2012 Mar; 27(3):873-9. PubMed ID: 22179765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
